Kansas Bioscience Authority

Flow Forward Medical is a company focused on enhancing vascular access sites to improve post-surgery success rates, particularly for patients undergoing hemodialysis. Founded in 2014 and headquartered in Olathe, Kansas, the company has developed the Arteriovenous Fistula Eligibility (AFE) System, which is a small, temporary external blood pump. This innovative device is designed to stimulate flow-mediated dilation of veins, thereby increasing the eligibility of patients for arteriovenous fistula (AVF) procedures and improving their surgical outcomes. By facilitating the establishment of reliable AVFs, Flow Forward Medical aims to reduce morbidity and mortality rates among hemodialysis patients and lower the overall costs associated with their care.

Innara Health, Inc. is a company focused on developing innovative neonatal care technologies aimed at improving the health and development of preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device designed to assist with the feeding of premature infants by promoting non-nutritive sucking skills and enhancing feeding outcomes. This device plays a crucial role in developmental feeding programs, allowing infants to engage in early and frequent nipping opportunities that help coordinate their suck, swallow, and breathe functions. Innara Health serves a wide range of stakeholders, including hospitals, neonatal intensive care units, clinicians, infants, children, and their families, with the goal of improving the quality of life for these vulnerable populations. Founded in 2006 and based in Olathe, Kansas, the company was previously known as KCBioMedix, Inc. before rebranding in 2013.

Artio Medical, Inc. is a medical device company focused on developing and commercializing catheter-based solutions for cardiovascular diseases. Based in Olathe, Kansas, the company specializes in endovascular devices designed for embolization of vessels, aneurysms, and other vascular structures. Its product offerings include Solus Gold and Solus Flex, both embolization devices featuring unique delivery systems, as well as Aneura and Endura, which combine coils and accessory balloons for the immediate occlusion of saccular and cerebral aneurysms, respectively. Artio Medical was founded in 2011 and was previously known as Metactive Medical, Inc. before rebranding in February 2020. The company operates as a subsidiary of Novita Therapeutics, LLC, and its innovations aim to enhance the speed and safety of vascular occlusion procedures for physicians.

Flow Forward Medical is a company focused on enhancing vascular access sites to improve post-surgery success rates, particularly for patients undergoing hemodialysis. Founded in 2014 and headquartered in Olathe, Kansas, the company has developed the Arteriovenous Fistula Eligibility (AFE) System, which is a small, temporary external blood pump. This innovative device is designed to stimulate flow-mediated dilation of veins, thereby increasing the eligibility of patients for arteriovenous fistula (AVF) procedures and improving their surgical outcomes. By facilitating the establishment of reliable AVFs, Flow Forward Medical aims to reduce morbidity and mortality rates among hemodialysis patients and lower the overall costs associated with their care.

Aratana Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutics for dogs and cats in the United States. Founded in 2010 and headquartered in Leawood, Kansas, the company focuses on addressing unmet medical needs in companion animal care through high-quality medicines. Its product portfolio includes various therapeutics, such as NOCITA for post-operative pain management in dogs, ENTYCE for appetite stimulation, and GALLIPRANT for pain and inflammation associated with osteoarthritis. Aratana is also advancing treatments for conditions like osteosarcoma in dogs and a range of therapies for cats, including a specialized formulation for pain management and treatments for feline herpes virus-induced conditions. The company has established collaboration agreements with other health organizations to enhance the development and commercialization of its products.

Aratana Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutics for dogs and cats in the United States. Founded in 2010 and headquartered in Leawood, Kansas, the company focuses on addressing unmet medical needs in companion animal care through high-quality medicines. Its product portfolio includes various therapeutics, such as NOCITA for post-operative pain management in dogs, ENTYCE for appetite stimulation, and GALLIPRANT for pain and inflammation associated with osteoarthritis. Aratana is also advancing treatments for conditions like osteosarcoma in dogs and a range of therapies for cats, including a specialized formulation for pain management and treatments for feline herpes virus-induced conditions. The company has established collaboration agreements with other health organizations to enhance the development and commercialization of its products.

Innara Health, Inc. is a company focused on developing innovative neonatal care technologies aimed at improving the health and development of preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device designed to assist with the feeding of premature infants by promoting non-nutritive sucking skills and enhancing feeding outcomes. This device plays a crucial role in developmental feeding programs, allowing infants to engage in early and frequent nipping opportunities that help coordinate their suck, swallow, and breathe functions. Innara Health serves a wide range of stakeholders, including hospitals, neonatal intensive care units, clinicians, infants, children, and their families, with the goal of improving the quality of life for these vulnerable populations. Founded in 2006 and based in Olathe, Kansas, the company was previously known as KCBioMedix, Inc. before rebranding in 2013.